UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Korea’s medical equipment industry too small in size, vulnerable'
by Nam Doo-hyun
2017-06-01 13:46
Growth of ‘pharmerging market’ to increase demand for generic drugs
by Nam Doo-hyun
2017-05-29 16:27
Patent war looming over genome editing tech
by Nam Doo-hyun
2017-05-25 14:12
Drugs halve death risks of uncomplicated hypertension patients
by Nam Doo-hyun
2017-05-22 18:24
Will Korea’s first stem cell therapy pass reexamination?
by Nam Doo-hyun
2017-05-22 13:43
라인
No more calls for drug price hikes based on inaccurate statistics: MOHW
by Nam Doo-hyun
2017-05-19 15:13
Young children of pharmaceutical firms’ owners have shares
by Nam Doo-hyun
2017-05-17 17:18
Government’s bio investment focuses on new drugs
by Nam Doo-hyun
2017-05-12 13:55
‘Korean pharmaceuticals should expand US export with new drugs’
by Nam Doo-hyun
2017-05-11 17:18
Investors focus on Moon-related shares
by Nam Doo-hyun
2017-05-10 20:02
라인
JW Pharmaceutical worst of 10 major drugmakers for women to work in
by Nam Doo-hyun
2017-04-28 12:07
How many Korean medical theses ranked in world’s top 1%
by Nam Doo-hyun
2017-04-19 18:42
How to approach China's biopharmaceutical market
by Nam Doo-hyun
2017-04-12 09:41
Companies have to cooperate to develop ‘surgery robot’: KEIT
by Nam Doo-hyun
2017-04-10 14:12
Sanofi's Japanese encephalitis vaccine ad fuels fear
by Nam Doo-hyun
2017-04-04 17:30
라인
Exports of healthcare system remain in doldrums: Why?
by Nam Doo-hyun
2017-04-03 14:33
Sale of Remsima rises amid prescription growth in US, Europe
by Nam Doo-hyun
2017-03-30 15:43
China delays merger of Canon and Toshiba Medical
by Nam Doo-hyun
2017-03-27 16:30
Family-controlled drugmaker draws attention
by Nam Doo-hyun
2017-03-24 11:20
'Integrated operating room reduces surgical time, staffs'
by Nam Doo-hyun
2017-03-23 11:24
-
이전
11
12
13
14
15
16
17
18
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top